Search results
Results from the WOW.Com Content Network
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry .
Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster results from a late-stage clinical trial. But far from being a reason to ...
Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. Read Next: Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges
Vertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by 5.4% over the past three months. Given its impressive performance...
For most growth-oriented investors, though, this stock is a buy at recent prices. Should you invest $1,000 in Vertex Pharmaceuticals right now? Before you buy stock in Vertex Pharmaceuticals ...
Vertex Pharmaceuticals (NASDAQ: VRTX) ... At recent prices, you can buy Vertex stock for about 35.2 times trailing free cash flow. This is a high multiple, but the business is growing fast enough ...
Take Vertex Pharmaceuticals (NASDAQ: VRTX), a leading biotech company whose average annual return since its 1991 initial public offering (IPO) is 15.1%. The drugmaker has grown by 10,310%. The ...
The stock price followed, climbing more than 145% over the past three years. Vertex remains an excellent investment, but investors also may want to try to get in on the next Vertex while the ...